Pfizer’s BNT162b2 COVID-19 vaccine was effective at reducing the risk of long COVID in pediatric patients during the Delta and Omicron periods of the pandemic, according to new research data published in the journal eClinicalMedicine.1 The authors said the …

… analyzed in the report: • Sanofi • Pfizer Inc. • Novartis AG • H. Lundbeck … . • Sun Pharmaceutical Industries Ltd. • Hikma Pharmaceuticals • Cipla Ltd. • Par Pharmaceutical. ✅ Buy …

Global Neuropathic Pain Market is estimated to valued at US$ 7.56 Billion in 2023 and expected to exhibit a CAGR of 6.2% during the forecast period 2023-2030 BURLINGAME, CA, UNITED STATES, December 20, 2024 /⁨EINPresswire.com⁩/ -- A complete study …

… subsidiary of China’s Betta Pharmaceuticals. The FDA on Wednesday … Ensacove is clearly better than Pfizer’s first-generation Xalkori. … Takeda’s Alunbrig and Pfizer’s third-generation med Lorbrena … billion) in sales, while Pfizer’s Lorbrena commanded $538 …

… . • Novartis International AG • Pfizer Inc. • Allergan Plc • Sun Pharmaceuticals • Fresenius Kabi • Sanofi …

Dive Brief: Pfizer on Tuesday said it anticipates bringing in between $61 billion and $64 billion in revenue next year, matching this year’s expected sum and within range of Wall Street forecasts. The pharmaceutical company boosted its 2024 guidance two …

Novo Nordisk’s newest obesity therapy has demonstrated “statistically significant and superior weight loss” compared to both the individual components and to placebo, according to a company news release.1 The drug, CagriSema, is a once-weekly, fixed-dose …

On December 20, 2024, the Food and Drug Administration granted accelerated approval to encorafenib (Braftovi, Array BioPharma Inc., a subsidiary of Pfizer Inc.) with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer (mCRC) with a BRAF …

FRIDAY, Dec. 20, 2024 (HealthDay News) -- For individuals with type 2 diabetes, examination with vibration-controlled transient elastography (VCTE) alongside retina scanning has a high acceptance rate, but false-positive findings seem to be common, …